• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Phase II evaluation of maytansine in patients with metastatic lung cancer.

作者信息

Eagan R T, Creagan E T, Ingle J N, Frytak S, Rubin J

出版信息

Cancer Treat Rep. 1978 Oct;62(10):1577-9.

PMID:709559
Abstract
摘要

相似文献

1
Phase II evaluation of maytansine in patients with metastatic lung cancer.
Cancer Treat Rep. 1978 Oct;62(10):1577-9.
2
Phase II trial of maytansine in patients with advanced colorectal carcinoma.美登素用于晚期结直肠癌患者的II期试验。
Cancer Treat Rep. 1978 Aug;62(8):1237-8.
3
Phase II study of maytansine in advanced sarcomas.
Cancer Treat Rep. 1983 Apr;67(4):401-2.
4
Phase II evaluation of maytansine in patients with advanced head and neck cancer.
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2061-2.
5
Phase II study of maytansine in advanced breast cancer.
Cancer Treat Rep. 1981 May-Jun;65(5-6):536-7.
6
Maytansine: a phase I study of an ansa macrolide with antitumor activity.
Cancer Treat Rep. 1978 Mar;62(3):435-8.
7
Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study.
Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1115-7.
8
Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group.美登素、低剂量氯脲霉素和高剂量氯脲霉素作为单一药物治疗晚期可测量胰腺腺癌的II期试验。胃肠道肿瘤研究组。
Cancer Treat Rep. 1985 Apr;69(4):417-20.
9
Results of a phase II study of maytansine in patients with breast carcinoma and melanoma.
Cancer Treat Rep. 1979 Mar;63(3):507-9.
10
Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).顺铂、美登素和氯脲霉素治疗小细胞肺癌的II期研究（EST 2578）
Cancer Treat Rep. 1982 Jun;66(6):1417-9.

引用本文的文献

1
Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models.依达曲妥珠单抗瑞妥昔单抗对三阴性乳腺癌的临床前肿瘤模型的作用。
Pharm Res. 2018 Apr 17;35(6):118. doi: 10.1007/s11095-018-2400-y.
2
Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program.儿科临床前试验计划对抗体-美登素偶联物 IMGN901（Lorvotuzumab mertansine）进行初步测试（第 1 阶段）。
Pediatr Blood Cancer. 2013 Nov;60(11):1860-7. doi: 10.1002/pbc.24647. Epub 2013 Jun 24.
3
Antibody-DM1 conjugates as cancer therapeutics.
抗体药物偶联物作为癌症治疗药物。
Cancer Lett. 2011 Aug 28;307(2):113-8. doi: 10.1016/j.canlet.2011.03.017. Epub 2011 Apr 9.
4
Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.晚期肺腺癌的单药化疗。综述。
Cancer Chemother Pharmacol. 1988;21(2):89-102. doi: 10.1007/BF00257354.